Read about studies of Sabril
If you visit PubMed (http://www.ncbi.nlm.nih.gov/pubmed), a service of the National Library of Medicine, you can read summaries of studies that have tested Sabril (vigabatrin), as well as other reports about this medication.
Here are links to some articles related to Sabril:
Dean C, Mosier M, Penry K. Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia. 1999;40(1):74-82. PMID: 9924905.
French JA, Mosier M, Walker S, et al. A double-blind, placebo-controlled study of vigabatrin (3 g/day) in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort. Neurology 1996;46(1):54-61. PMID: 8559421.
Hardus P, Verduin WM, Engelsman M, et al. Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia. 2001;42(2):262-267. PMID: 11240600
Levinson DF, Devinsky O: Psychiatric adverse events during vigabatrin therapy. Neurology. 1999;53(7):1503-1511. PMID: 10534259
Reviewed February 2004 by Steven C. Schachter, MD, epilepsy.com Editorial Board.
